Expertise in
5
conditions

Andrew T. Ha

Toronto, ON, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
5
conditions
Toronto, ON, CA 

Overview

Andrew Ha practices practicing medicine in Toronto, Canada.

Mr. Ha is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Atrial Fibrillation, Familial Ventricular Tachycardia, Ventricular Fibrillation, Cardiac Ablation, and Tissue Biopsy.

He is actively involved in clinical research, co-authoring 104 peer reviewed articles and participating in 8 clinical trials.

Gender

Male

Locations

Toronto, ON, Canada
Other Locations
Toronto, Canada
Mississauga, ON, Canada
Hamilton, ON, Canada
Halifax, NS, Canada
Newmarket, ON, Canada
Ottawa, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Cardiac Sarcoidosis Multi-Center Randomized Controlled Trial
Cardiac Sarcoidosis Multi-Center Randomized Controlled Trial
Enrollment Status: Recruiting
Publish Date: May 05, 2026
Intervention Type: Drug
Study Drugs: Prednisone, Methotrexate
Study Phase: Phase 3
A Randomized Ablation-based Atrial Fibrillation Rhythm Control Versus Rate Control Trial in Patients With Heart Failure and High Burden Atrial Fibrillation
A Randomized Ablation-based Atrial Fibrillation Rhythm Control Versus Rate Control Trial in Patients With Heart Failure and High Burden Atrial Fibrillation
Enrollment Status: Completed
Publish Date: May 11, 2026
Intervention Type: Other, Procedure
Study Phase: Not Applicable
Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation
Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation
Enrollment Status: Completed
Publish Date: April 30, 2026
Intervention Type: Device
Study Phase: Not Applicable
The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial
The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial
Enrollment Status: Completed
Publish Date: October 06, 2025
Intervention Type: Drug
Study Drugs: Rivaroxaban, Acetylsalicylic acid
Study Phase: Phase 4
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Enrollment Status: Completed
Publish Date: May 30, 2025
Intervention Type: Device, Other
Study Phase: Phase 3
Randomized Ablation-based Atrial Fibrillation Rhythm-control Versus Rate-control Trial in Patients With Heart Failure and High-burden Atrial Fibrillation Extend
Randomized Ablation-based Atrial Fibrillation Rhythm-control Versus Rate-control Trial in Patients With Heart Failure and High-burden Atrial Fibrillation Extend
Enrollment Status: Completed
Publish Date: March 24, 2025
Post-Surgical Enhanced Monitoring for Cardiac Arrhythmias and Atrial Fibrillation (SEARCH-AF): A Randomized Controlled Trial
Post-Surgical Enhanced Monitoring for Cardiac Arrhythmias and Atrial Fibrillation (SEARCH-AF): A Randomized Controlled Trial
Enrollment Status: Terminated
Publish Date: June 18, 2021
Intervention Type: Device, Other
Study Phase: Not Applicable
View 6 Less Clinical Trials

103 Total Publications

Left atrial myopathy development and progression in atrial fibrillation patients with recurrent left atrial ablation procedures: the LAMP-AF study.
Left atrial myopathy development and progression in atrial fibrillation patients with recurrent left atrial ablation procedures: the LAMP-AF study.
Journal: Heart rhythm
Published: March 22, 2026

Frequently Asked Questions about Andrew T. Ha

Is Andrew T. Ha a top-rated expert for Atrial Fibrillation?

MediFind is an objective health platform that identifies experts based on real-world data. Andrew T. Ha is classified as an Distinguished expert for Atrial Fibrillation, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Andrew T. Ha participate in research or clinical trials?

Yes. Andrew T. Ha has published 103 articles and abstracts on conditions like Atrial Fibrillation. You can view a list of Andrew T. Ha's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ha's expertise for a condition
ConditionClose
    View All 13 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile